Phase II Evaluation of Adjuvant Hyperfractionated Radiation and Docetaxel for HPV Associated Oropharynx Cancer
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Docetaxel (Primary)
- Indications Oropharyngeal cancer
- Focus Therapeutic Use
- 27 Sep 2017 Results from this trial were presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), according to an ASTRO media release.
- 25 Sep 2017 Results presented in an American Society for Radiation Oncology (ASTRO) Media Release.
- 10 Jun 2017 Biomarkers information updated